Back
Enliven Therapeutics Quote, Financials, Valuation and Earnings
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
58
ELVN
Enliven Therapeutics
Last Price:
27.82
Seasonality Move:
-12%
7 Day Trial
ALL ACCESS PASS
$
7
Beginner's Guide To Growing A Small Investment
Click here to download your free copy now!Enliven Therapeutics Price Quote
$27.82
-0.56 (-1.97%)
(Updated: October 31, 2024 at 6:55 PM ET)
Enliven Therapeutics Key Stats
Buy
58
Enliven Therapeutics (ELVN)
is a Buy
Day range:
$28.00 - $29.02
52-week range:
$9.80 - $30.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.42%
Volume:
115.9K
Avg. volume:
310K
1-year change:
136.7%
Market cap:
$1.3B
Revenue:
$0
EPS:
$-1.92
How Much Does Enliven Therapeutics Make?
Data Unavailable
Is Enliven Therapeutics Growing As A Company?
Data Unavailable
Enliven Therapeutics Stock Price Performance
-
Did Enliven Therapeutics Stock Go Up Last Month?
Enliven Therapeutics share price went up by 11.12% last month -
Did ELVN's Share Price Rise Over The Last Year?
ELVN share price rose by 136.7% over the past 1 year
What Is Enliven Therapeutics 52-Week High & Low?
-
What Is Enliven Therapeutics’s 52-Week High Share Price?
Enliven Therapeutics has traded as high as $30.03 over the past 52 weeks -
What Is Enliven Therapeutics’s 52-Week Low Share Price?
Enliven Therapeutics has traded as low as $9.80 over the past 52 weeks
Enliven Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Enliven Therapeutics?
-
How Much Debt Does Enliven Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Enliven Therapeutics Have?
Cash and short term investments quarterly total is $312.4M -
What Is Enliven Therapeutics’s Book Value Per Share?
Book value per share is 6.46
Is Enliven Therapeutics Cash Flow Positive?
-
What Is ELVN Cash Flow From Operations?
Cash flow from operations (TTM) is -$72.2M -
What Is Enliven Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $91.7M -
What Is Enliven Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$48.4M
Enliven Therapeutics Return On Invested Capital
Data Unavailable
Enliven Therapeutics Earnings Date & Stock Price
-
What Is Enliven Therapeutics's Stock Price Today?
A single share of ELVN can be purchased today for 28.38 -
What Is Enliven Therapeutics’s Stock Symbol?
Enliven Therapeutics trades on the nasdaq under the ticker symbol: ELVN -
When Is Enliven Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Enliven Therapeutics is scheduled on November 8, 2024 -
When Is ELVN's next ex-dividend date?
Enliven Therapeutics's next ex-dividend date is November 1, 2024 -
How To Buy Enliven Therapeutics Stock?
You can buy Enliven Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Enliven Therapeutics Competitors
-
Who Are Enliven Therapeutics's Competitors?
Below is a list of companies who compete with Enliven Therapeutics or are related in some way:
Enliven Therapeutics Dividend Yield
-
What Is ELVN Dividend Yield?
Enliven Therapeutics’s dividend yield currently is 0% -
What Is Enliven Therapeutics’s Payout Ratio?
Enliven Therapeutics’s payout ratio is 0% -
When Did Enliven Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 1, 2024 -
What Is Enliven Therapeutics’s Dividend Per Share?
Enliven Therapeutics pays a dividend of $0.00 per share
Enliven Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 35.60 |
| Upside from Last Price: | 25.44% |